LBA Angel Syndicate closes £250k seed round into Orbel Health Limited
Early stage London based Healthcare company Orbel Health Limited has closed its £250k round with the entire investment raised from an LBA syndicate which included sector specialists. The company has developed a unique patented hand disinfector dispenser to tackle all the problems associated with hand hygiene. The seed funding will allow the company to further develop and trial its product which has already caught the attention of a major international company involved in the b2c markets. The b2b applications in the international healthcare market are also being pursued by the company.
The company’s founder and inventor Adam Sutcliffe developed the product with assistance from Design London, a joint venture between the Royal College of Art and Imperial College.
Adam Sutcliffe, CTO of Orbel comments: "Apart from being exceptionally fruitful, the whole process of working with LBA, and the guidance they have provided, has been excellent. The future for Orbel™ is exceptionally bright and I hope that our involvement, and success, with LBA will encourage more Design London incubees to seek their help in gaining second round support."
Anthony Clarke, Managing Director of London Business Angels comments: “LBA is delighted to have helped Adam and Orbel Healthcare to close this significant seed round which will allow the business to take its unique product to market. The exposure that the company received from presenting at LBA also led to the subsequent commercial interest from the major corporate. This demonstrates the power and reach of LBA’s network which is all about providing smart money to start ups.”
London Business Angels
Anthony Clarke, Managing Director
Tel: +44 (0)20 7321 5672
E-mail: enquiries@lbangels.co.uk
Web: www.lbangels.co.uk
About London Business Angels
LBA is one of the most experienced private angel networks in the UK. Since the early 1980s the network has been connecting innovating fast growth small and medium sized enterprises with investment through our network of business angel investors. LBA, part of Angel Capital Group, is professionally managed by a highly experienced management team, leveraging over 15 years’ experience in the early stage investment marketplace as established leaders in the development of new angel-led early stage investment initiatives, and nearly 30 years’ investing experience through the LBA network. LBA is a founding member of the British Business Angels Association, the industry's best practice trade association, and is also a member of EBAN, the European Business Angels Network.
About the LBA EIS Approved RoundTable Syndicate Fund
The LBA EIS Approved RoundTable Syndicate Fund is the culmination of 30 years’ experience of pioneering innovation in the UK Angel investment market. This FSA regulated HMRC Approved EIS Fund offers LBA Investors an innovative way to acquire a portfolio of investments, while taking advantage of the personal tax relief offered by the Enterprise Investment Scheme. The First £300k LBA EIS RoundTable Fund 2010 was fully invested in January 2011, making four investments in leading edge technologies during the previous year, spread across a range of sectors: Eykona (medtech); Syrinix (cleantech); ipadio (mobile); The Electrospinning Company (nanotech).
Following the successful 2010 Fund, the LBA EIS Approved RoundTable Syndicate Fund 2011-12 closed for subscriptions on 13 May 2011, being 40% larger at £420k. The fund invested in 5 leading edge technologies spread across a range of sectors: Camstent (medtech), Momentum Bioscience (medtech), Phase Vision (high value manufacturing), Michelson Diagnostics (medtech), Isotera (cleantech)
The LBA EIS Roundtable Syndicate Fund 2012, closed for subsciprtions on 5th April 2012, being the largest raised to date at £455k. The fund will seek to invest in 5-6 early stage companies in the forthcoming year.
